Calcimedica
Calcimedica is a clinical-stage biotechnology company targeting calcium release-activated calcium (CRAC) channels for the treatment of inflammatory and autoimmune disorders and organ transplant rejection.
12
Funding Rounds
$108.1m
Money raised
Funding
Funding series
Funding Series Analysis
The company Calcimedica has raised a total of $26m in funding over 12 rounds.
Key Insights:
- CalciMedica Series C round, May 2020: $15m
- Calcimedica Series C round: $4m
- Calcimedica Series B round: $5.5m
- Calcimedica Series A round: $1.5m
- CalciMedica Inc funding round, October 2012: $4.6m
- CalciMedica Inc funding round, July 2010: $9m
- CalciMedica Inc funding round, September 2011: $4m
- CalciMedica Inc funding round, March 2012: $13.2m
- CalciMedica Inc funding round, July 2013: $9m
- CalciMedica Inc funding round, April 2014: $13.09m
- CalciMedica Inc funding round, May 2020: $17.19m
- CalciMedica Inc funding round, November 2009: $12m
CalciMedica Series C round, May 2020
$15m
Calcimedica Series C round
$4m
Calcimedica Series B round
$5.5m
Calcimedica Series A round
$1.5m
CalciMedica Inc funding round, October 2012
$4.6m
CalciMedica Inc funding round, July 2010
$9m
CalciMedica Inc funding round, September 2011
$4m
CalciMedica Inc funding round, March 2012
$13.2m
CalciMedica Inc funding round, July 2013
$9m
CalciMedica Inc funding round, April 2014
$13.09m
CalciMedica Inc funding round, May 2020
$17.19m
CalciMedica Inc funding round, November 2009
$12m
Industries
Calcimedica is active in the following industries: